 |
Previous Article | Next Article 
Volume 17, Number 11,
Issue of June 1, 1997
pp. 4415-4425
Copyright ©1997 Society for Neuroscience
Metabotropic Glutamate Agonist-Induced Rotation: A
Pharmacological, FOS Immunohistochemical, and
[14C]-2-Deoxyglucose Autoradiographic Study
Received Jan. 30, 1997; revised March 13, 1997; accepted March 18, 1997.
Jennifer A. Feeley Kearney1, 3,
Kirk A. Frey1, 2, 3, 4, and
Roger L. Albin1, 3, 5
1 Neuroscience Program, 2 The Mental Health
Research Institute, and Departments of 3 Neurology and
4 Internal Medicine, Division of Nuclear Medicine, The
University of Michigan, Ann Arbor, Michigan 48109, and
5 The Geriatrics Research, Education and Clinical Center,
Veterans Administration Medical Center, Ann Arbor, Michigan 48105
Metabotropic glutamate receptors (mGluRs) are a major class
of excitatory amino acid receptors. Eight mGluR subtypes, coupled to a
variety of effector systems, have been cloned. These receptors have
been classified into three groups based on amino acid sequence homology, effector systems, and pharmacological profile. Group I mGluRs
increase phosphoinositide turnover, whereas groups II and III mGluRs
are negatively coupled to adenylyl cyclase. The striatum possesses a
high density of mGluR binding sites, and several mGluR mRNAs and
proteins are expressed by striatal neurons. In rats, unilateral
striatal injection of the nonsubtype selective mGluR agonist
1-aminocyclopentane-1S,3R-dicarboxylic acid (1S,3R-ACPD) results in
contralateral rotation with delayed onset, thought to be secondary to
an increase in dopamine release. We sought to determine the mGluR
subtype(s) involved, the modulation of the rotation by other basal
ganglia neurotransmitter systems, and the functional anatomy underlying
the rotational behavior. The group I mGluR agonist
3,5-dihydroxyphenylglycine (DHPG) induced contralateral rotation in a
dose-dependent manner, whereas group II and group III agonists were
ineffective. Rotation induced by DHPG or 1S,3R-ACPD was attenuated by
group I antagonists, but not by group II or group III antagonists. This
suggests that the rotation is mediated by group I mGluRs. Rotation
induced by DHPG or 1S,3R-ACPD was attenuated by pretreatment with
antagonists at muscarinic cholinergic, adenosine A2,
dopamine D2, or dopamine D1 receptors.
Examination of FOS-like immunoreactivity after group I and group II
mGluR agonist administration suggests increased activity in the
striatopallidal pathway. However, [14C]-2-deoxyglucose
uptake studies indicate increased activity in nuclei of the
striatopallidal (indirect) pathway, particularly in the subthalamic
nucleus, only after group I mGluR activation.
Key words:
metabotropic glutamate receptor;
basal ganglia;
subthalamic nucleus;
striatum;
dopamine;
adenosine A2 receptors;
muscarinic receptors
This article has been cited by other articles:

|
 |

|
 |
 
F. Ferraguti, L. Crepaldi, and F. Nicoletti
Metabotropic Glutamate 1 Receptor: Current Concepts and Perspectives
Pharmacol. Rev.,
December 1, 2008;
60(4):
536 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kachroo, L. R. Orlando, D. K. Grandy, J.-F. Chen, A. B. Young, and M. A. Schwarzschild
Interactions between Metabotropic Glutamate 5 and Adenosine A2A Receptors in Normal and Parkinsonian Mice
J. Neurosci.,
November 9, 2005;
25(45):
10414 - 10419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Chen, S. Fredduzzi, E. Bastia, L. Yu, R. Moratalla, E. Ongini, and M. A. Schwarzschild
Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: Implications for the treatment of dyskinesias in Parkinson's disease
Neurology,
December 9, 2003;
61(90116):
S74 - 81.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Nishi, F. Liu, S. Matsuyama, M. Hamada, H. Higashi, A. C. Nairn, and P. Greengard
Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling
PNAS,
February 4, 2003;
100(3):
1322 - 1327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Kearney, D. A. Buchner, G. de Haan, M. Adamska, S. I. Levin, A. R. Furay, R. L. Albin, J. M. Jones, M. Montal, M. J. Stevens, et al.
Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Nav1.6)
Hum. Mol. Genet.,
October 15, 2002;
11(22):
2765 - 2775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mao and J. Q. Wang
Glutamate Cascade to cAMP Response Element-Binding Protein Phosphorylation in Cultured Striatal Neurons through Calcium-Coupled Group I Metabotropic Glutamate Receptors
Mol. Pharmacol.,
September 1, 2002;
62(3):
473 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Liu, X.-H. Ma, J. Ule, J. A. Bibb, A. Nishi, A. J. DeMaggio, Z. Yan, A. C. Nairn, and P. Greengard
Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors
PNAS,
September 25, 2001;
98(20):
11062 - 11068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Marino, M. Wittmann, S. R. Bradley, G. W. Hubert, Y. Smith, and P. J. Conn
Activation of Group I Metabotropic Glutamate Receptors Produces a Direct Excitation and Disinhibition of GABAergic Projection Neurons in the Substantia Nigra Pars Reticulata
J. Neurosci.,
September 15, 2001;
21(18):
7001 - 7012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Awad, G. W. Hubert, Y. Smith, A. I. Levey, and P. J. Conn
Activation of Metabotropic Glutamate Receptor 5 Has Direct Excitatory Effects and Potentiates NMDA Receptor Currents in Neurons of the Subthalamic Nucleus
J. Neurosci.,
November 1, 2000;
20(21):
7871 - 7879.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|